Cargando…
Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121140/ https://www.ncbi.nlm.nih.gov/pubmed/37169611 http://dx.doi.org/10.1016/j.medcli.2023.02.022 |
| _version_ | 1785029319079231488 |
|---|---|
| author | Kleebayoon, Amnuay Wiwanitkit, Viroj |
| author_facet | Kleebayoon, Amnuay Wiwanitkit, Viroj |
| author_sort | Kleebayoon, Amnuay |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10121140 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101211402023-04-24 Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients Kleebayoon, Amnuay Wiwanitkit, Viroj Med Clin (Barc) Letter to the Editor Elsevier España, S.L.U. 2023-04-21 /pmc/articles/PMC10121140/ /pubmed/37169611 http://dx.doi.org/10.1016/j.medcli.2023.02.022 Text en © 2023 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Kleebayoon, Amnuay Wiwanitkit, Viroj Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients |
| title | Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients |
| title_full | Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients |
| title_fullStr | Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients |
| title_full_unstemmed | Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients |
| title_short | Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients |
| title_sort | correspondence on anti-sars-cov-2 antibodies and clinical outcome of hospitalized covid-19 patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121140/ https://www.ncbi.nlm.nih.gov/pubmed/37169611 http://dx.doi.org/10.1016/j.medcli.2023.02.022 |
| work_keys_str_mv | AT kleebayoonamnuay correspondenceonantisarscov2antibodiesandclinicaloutcomeofhospitalizedcovid19patients AT wiwanitkitviroj correspondenceonantisarscov2antibodiesandclinicaloutcomeofhospitalizedcovid19patients |